Brixton Biosciences
United StatesEntry
2024
Hold
2yr
Status
Active
Who owns Brixton Biosciences?
Brixton Biosciences is currently owned by SV Health Managers through Medtech Convergence Fund (2020 vintage), since 2024.
Hand-verified · updated 2026-08-02
More from Medtech Convergence Fund
Other portfolio companies in the same fund.
More SV Health Managers portfolio companies
From the same investor, across funds.
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Brixton Biosciences
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Brixton Biosciences.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue